MPR Weekly Dose 78 - Vaccine authorized for adolescents; Postoperative pain Tx approval; Insulin products recalled; Treatment Fast Tracked for facioscapulohumeral muscular dystrophy episode artwork

EPISODE · May 14, 2021 · 13 MIN

MPR Weekly Dose 78 - Vaccine authorized for adolescents; Postoperative pain Tx approval; Insulin products recalled; Treatment Fast Tracked for facioscapulohumeral muscular dystrophy

from MPR Weekly Dose

This week we have news of a COVID-19 vaccine authorization expanded for adolescents; A new postoperative pain treatment; There's a new insulin smart pen devices; Insulin products are recalled; And the FDA grants fast track status to a potential treatment for the rare disease, FSHD.

Episode metadata supplied by the publisher feed · Published May 14, 2021

Embed this episode

Ready to play

MPR Weekly Dose 78 - Vaccine authorized for adolescents; Postoperative pain Tx approval; Insulin products recalled; Treatment Fast Tracked for facioscapulohumeral muscular dystrophy

0:00 13:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 13 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on May 14, 2021.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!